Influenza GSK - Search Videos

Company | GSK US

Company | GSK US

Life at GSK | GSK

Life at GSK | GSK

We innovate faster to outsmart disease | GSK

We innovate faster to outsmart disease | GSK

3.8M viewsApr 14, 2025

Tech | GSK

We are a company on a mission to change healthcare and improve the quality of life for people and communities all over the world: http://www.gsk.com/change By working in partnership, we hope to overcome some of the biggest challenges in global health. We want to improve access to vital medicine for the people who need it most; transform everyday health; develop sustainable healthcare systems and inspire the next generation of scientists to solve the problems of the future. We are GSK and this is

We are a company on a mission to change healthcare and improve the quality of life for people and communities all over the world: http://www.gsk.com/change By working in partnership, we hope to overcome some of the biggest challenges in global health. We want to improve access to vital medicine for the people who need it most; transform everyday health; develop sustainable healthcare systems and inspire the next generation of scientists to solve the problems of the future. We are GSK and this is

10.8K viewsApr 17, 2015

Anti-GSK3 alpha/beta Antibodies | Invitrogen

Anti-GSK3 alpha/beta Antibodies | Invitrogen

thermofisher.com

Unlocking the secrets of the immune system. | GSK

Unlocking the secrets of the immune system. | GSK

1.8M viewsMar 7, 2019

We’re building on our existing relationship with Vir Biotechnology, to include R&D of new therapeutics for influenza and other respiratory viruses. The expanded collaboration will combine both companies’ expertise in immunology and infectious diseases to accelerate the development of promising monoclonal antibody candidates. https://www.gsk.com/en-gb/ | GSK

3.3K viewsFeb 17, 2021

Oncology | GSK

GSK mother and baby homes information service | GSK

Purpose, strategy and culture | GSK US

Research and development | GSK

Research and development approach | GSK

New technologies are helping to shape the vaccines of the future. Tune in next Thursday for more 60 seconds of science. | GSK

6.2K viewsApr 19, 2018

It’s one vaccination away to keep your child flu-protected by taking the Annual Flu Vaccination, along with maintaining hygiene & social distancing. For more information talk to your child’s Pediatrician & get to digital vaccination tracker visit My Vaccination Hub - https://www.myvaccinationhub.in/en/vaccination-by-disease/influenza #firstcry #firstcryparenting #FaislaSahiZindagiSahi #MyVaccinationHub #HealthkaPassport #vaccination #vaccines #flu #vaccine2023 #vaccination2023 | FirstCry Parenti

191K viewsJul 13, 2023

FacebookFirstCry Parenting

Our breakthrough science in your hands | GSK

3.2M viewsJul 6, 2017

Vaccines have seen a significant advance over the last century, with new technologies like adjuvants, making previously impossible vaccines a reality. See more 60 seconds of science to learn more about the future of vaccines: gsk.to/2ys8uGK | GSK

11.2K viewsOct 5, 2017

Helping unlock the secrets of the immune system. | GSK

2.5M viewsJul 24, 2019

The logic of biologic medicines: advancing care for people with immune-mediated conditions | GSK

Improving access to healthcare | GSK

GSK Picks Upper Merion for an AI-Powered Biologics Hub

MSNMichael-Paul Kidd

For people living with Chronic Obstructive Pulmonary Disease (COPD) several factors contribute to a sustained decline in lung function. Each new exacerbation of COPD aggravates the disease. Respiratory pathogens such as pertussis, Influenza, RSV and streptococcus pneumoniae are common reasons for exacerbations; and they worsen overall outcomes. For people like Peter, preventing infections can improve clinical symptoms and improve quality of life. #WorldCOPDDay | GSK

946 viewsNov 15, 2023

Your risk of infection from respiratory syncytial virus (RSV) can increase due to certain conditions, like some ongoing illnesses or living in long-term care. How many of the below are you familiar with? Do you know someone who might be at risk of RSV? Learn more below 👇 or talk to your healthcare provider about how you can protect yourself and your loved ones from RSV | GSK

423 views8 months ago

Receiving more than one vaccine during the same visit to your healthcare provider is also known as co-administration. What are some ways that vaccination co-administration could benefit you and your community? Check out the video below from Professor Isabel Leroux-Roels, a vaccine expert, to learn more 👇 | GSK

819 views8 months ago

New global survey identifies several factors – including delays in optimal care during the COVID-19 pandemic – that could be contributing to an increased risk of organ damage in some people living with #lupus. | GSK

1.5M viewsDec 13, 2022

Did you know that overall, infectious diseases and HIV represent around two-thirds of our pipeline and our primary focus for R&D? Learn more about how we are developing ways to both treat and prevent infectious diseases: | GSK

1.5K viewsApr 11, 2023

Almost one-fifth of patients with gynaecologic cancers who participated in a recent GSK-sponsored survey, conducted by The Harris Poll, say they felt no one understands their personal experience. Listening to the experiences of people living with cancer is critical to finding ways to better understand and support patients, beyond treatment. Learn more from Jennifer Garam, an ovarian cancer survivor, and Nina Mojas, SVP, Oncology Global Product Strategy at GSK, who discuss the Your Cancer Is Our

814 viewsMar 17, 2025

Do you know what our Shopper Science Labs do? Follow our journey through the labs this week to find out how we test what consumers want from our products. | GSK

4.2K viewsJan 29, 2018

Using our science for global health | GSK

See more